Update Type: New Tests
Test Updated: 06/09/2021
Test Overview
Test Methodology

Capillary electrophoresis

Test Usage

Used to monitor minimal residual disease in Philadelphia chromosome positive CML or AML patients being treated with tyrosine kinase inhibitors.

Reference Range *

Interpretive report provided

Test Details
Analytic Time

4 - 8 days

Soft Order Code
BCBCM
Laboratory
Sendout
Reference Laboratory
Versiti (#4502 and 4504)
Section
Special Testing
Specimen Requirements
Collection

Collect specimen and transfer to an EDTA lavender top tube. Send intact bone marrow to Specimen Processing room temperature

Normal Volume
5 mL bone marrow
Minimum Volume
3 mL bone marrow
Storage Temperature
Ambient
Additional Information

Test performed by Versiti

Billing
CPT Code
81206, 81207, 81208
Fee Code
40393
NY State Approved
No